Skip to Main Content

Author Details

Jung Kim
Clinical Genetics Branch, National Cancer Institute
2017
31
9
PMIDPaper TitleJournal TitlePublished Year
37246069Germline Exome Sequencing for Men with Testicular Germ Cell Tumor Reveals Coding Defects in Chromosomal Segregation and Protein-targeting Genes.Eur Urol2024
37688579Germline pathogenic variants in neuroblastoma patients are enriched in BARD1 and predict worse survival.J Natl Cancer Inst2024
37246069Germline Exome Sequencing for Men with Testicular Germ Cell Tumor Reveals Coding Defects in Chromosomal Segregation and Protein-targeting Genes.Eur Urol2024
37688579Germline pathogenic variants in neuroblastoma patients are enriched in BARD1 and predict worse survival.J Natl Cancer Inst2024
34331184Unusual phenotypes in patients with a pathogenic germline variant in DICER1.Fam Cancer2023
37585199Estimated Prevalence, Tumor Spectrum, and Neurofibromatosis Type 1-Like Phenotype of CDKN2A-Related Melanoma-Astrocytoma Syndrome.JAMA Dermatol2023
38084291Specifications of the ACMG/AMP Variant Classification Guidelines for Germline <i>DICER1</i> Variant Curation.Hum Mutat2023
37883719Intronic Germline <i>DICER1</i> Variants in Patients With Sertoli-Leydig Cell Tumor.JCO Precis Oncol2023
38076939AutoGVP: a dockerized workflow integrating ClinVar and InterVar germline sequence variant classification.bioRxiv2023
37386403Increase in power by obtaining 10 or more controls per case when type-1 error is small in large-scale association studies.BMC Med Res Methodol2023
36696392Inflated expectations: Rare-variant association analysis using public controls.PLoS One2023
36747619Germline pathogenic variants in 786 neuroblastoma patients.medRxiv2023
36692560Estimated Prevalence and Clinical Manifestations of UBA1 Variants Associated With VEXAS Syndrome in a Clinical Population.JAMA2023
36541551Alternative lengthening of telomeres (ALT) in pediatric high-grade gliomas can occur without ATRX mutation and is enriched in patients with pathogenic germline mismatch repair (MMR) variants.Neuro Oncol2023
37492101OpenPBTA: The Open Pediatric Brain Tumor Atlas.Cell Genom2023
34331184Unusual phenotypes in patients with a pathogenic germline variant in DICER1.Fam Cancer2023
37492101OpenPBTA: The Open Pediatric Brain Tumor Atlas.Cell Genom2023
38084291Specifications of the ACMG/AMP Variant Classification Guidelines for Germline <i>DICER1</i> Variant Curation.Hum Mutat2023
38076939AutoGVP: a dockerized workflow integrating ClinVar and InterVar germline sequence variant classification.bioRxiv2023
37585199Estimated Prevalence, Tumor Spectrum, and Neurofibromatosis Type 1-Like Phenotype of CDKN2A-Related Melanoma-Astrocytoma Syndrome.JAMA Dermatol2023
37883719Intronic Germline <i>DICER1</i> Variants in Patients With Sertoli-Leydig Cell Tumor.JCO Precis Oncol2023
37386403Increase in power by obtaining 10 or more controls per case when type-1 error is small in large-scale association studies.BMC Med Res Methodol2023
36696392Inflated expectations: Rare-variant association analysis using public controls.PLoS One2023
36747619Germline pathogenic variants in 786 neuroblastoma patients.medRxiv2023
36692560Estimated Prevalence and Clinical Manifestations of UBA1 Variants Associated With VEXAS Syndrome in a Clinical Population.JAMA2023
36541551Alternative lengthening of telomeres (ALT) in pediatric high-grade gliomas can occur without ATRX mutation and is enriched in patients with pathogenic germline mismatch repair (MMR) variants.Neuro Oncol2023
36409970Gene-Level Associations in Patients With and Without Pathogenic Germline Variants in <i>CDKN2A</i> and Pancreatic Cancer.JCO Precis Oncol2022
35805029A Genome-First Approach to Estimate Prevalence of Germline Pathogenic Variants and Risk of Pancreatic Cancer in Select Cancer Susceptibility Genes.Cancers (Basel)2022
36409970Gene-Level Associations in Patients With and Without Pathogenic Germline Variants in <i>CDKN2A</i> and Pancreatic Cancer.JCO Precis Oncol2022
35776903Genetic testing in severe aplastic anemia is required for optimal hematopoietic cell transplant outcomes.Blood2022
35717579Rare germline deleterious variants increase susceptibility for lung cancer.Hum Mol Genet2022
35805029A Genome-First Approach to Estimate Prevalence of Germline Pathogenic Variants and Risk of Pancreatic Cancer in Select Cancer Susceptibility Genes.Cancers (Basel)2022
35717579Rare germline deleterious variants increase susceptibility for lung cancer.Hum Mol Genet2022
35776903Genetic testing in severe aplastic anemia is required for optimal hematopoietic cell transplant outcomes.Blood2022
33051549Endemic Burkitt Lymphoma in second-degree relatives in Northern Uganda: in-depth genome-wide analysis suggests clues about genetic susceptibility.Leukemia2021
33630087A Genome-First Approach to Characterize DICER1 Pathogenic Variant Prevalence, Penetrance, and Phenotype.JAMA Netw Open2021
33526862Author Correction to: Endemic Burkitt lymphoma in second-degree relatives in Northern Uganda: in-depth genome-wide analysis suggests clues about genetic susceptibility.Leukemia2021
34308104Frequency of Pathogenic Germline Variants in Cancer-Susceptibility Genes in the Childhood Cancer Survivor Study.JNCI Cancer Spectr2021
33402588The efficacy and safety of onartuzumab in patients with solid cancers: A meta-analysis of randomized trials.Indian J Cancer2021
33051549Endemic Burkitt Lymphoma in second-degree relatives in Northern Uganda: in-depth genome-wide analysis suggests clues about genetic susceptibility.Leukemia2021
34964002Identification of Genetic Risk Factors for Familial Urinary Bladder Cancer: An Exome Sequencing Study.JCO Precis Oncol2021
34493867Genomic and evolutionary classification of lung cancer in never smokers.Nat Genet2021
33630087A Genome-First Approach to Characterize DICER1 Pathogenic Variant Prevalence, Penetrance, and Phenotype.JAMA Netw Open2021
33526862Author Correction to: Endemic Burkitt lymphoma in second-degree relatives in Northern Uganda: in-depth genome-wide analysis suggests clues about genetic susceptibility.Leukemia2021
34964002Identification of Genetic Risk Factors for Familial Urinary Bladder Cancer: An Exome Sequencing Study.JCO Precis Oncol2021
34493867Genomic and evolutionary classification of lung cancer in never smokers.Nat Genet2021
34308104Frequency of Pathogenic Germline Variants in Cancer-Susceptibility Genes in the Childhood Cancer Survivor Study.JNCI Cancer Spectr2021
33402588The efficacy and safety of onartuzumab in patients with solid cancers: A meta-analysis of randomized trials.Indian J Cancer2021
33158809Lack of pathogenic germline DICER1 variants in males with testicular germ-cell tumors.Cancer Genet2020
31982544Population Frequency of Fanconi Pathway Gene Variants and Their Association with Survival After Hematopoietic Cell Transplantation for Severe Aplastic Anemia.Biol Blood Marrow Transplant2020
  • 1 - 50 of 62

Recommended Authors

University of Toronto
Career Start Year 2015
Number of shared co-authors 2
St. Jude Children's Research Hospital
Career Start Year 2014
Number of shared co-authors 2
Invitae Corporation
Career Start Year 2013
Number of shared co-authors 0
Department of Biology at Brigham Young University
Career Start Year 2013
Number of shared co-authors 5
Invitae Corporation
Career Start Year 2012
Number of shared co-authors 0
Frederick National Laboratory for Cancer Research (FNLCR), Inc.
Career Start Year 2012
Number of shared co-authors 21
Invitae Corporation
Career Start Year 2011
Number of shared co-authors 0
University of Pennsylvania
Career Start Year 2010
Number of shared co-authors 2
The University of North Carolina at Chapel Hill
Career Start Year 2009
Number of shared co-authors 7
University of Oslo
Career Start Year 2007
Number of shared co-authors 0
Center for Inherited Disease Research, Johns Hopkins School of Medicine
Career Start Year 2007
Number of shared co-authors 6
Children's Cancer Institute, Lowy Cancer Research Centre
Career Start Year 2006
Number of shared co-authors 6
Institute of Genetics and Cancer, University of Edinburgh
Career Start Year 2006
Number of shared co-authors 1
Institute for Genomic Medicine, Nationwide Children's Hospital
Career Start Year 2005
Number of shared co-authors 2
H. Lee Moffitt Cancer Center and Research Institute
Career Start Year 2005
Number of shared co-authors 3
University of British Columbia
Career Start Year 2005
Number of shared co-authors 6
QIMR Berghofer Medical Research Institute
Career Start Year 2005
Number of shared co-authors 3
Memorial Sloan Kettering Cancer Center
Career Start Year 2004
Number of shared co-authors 5
University of California
Career Start Year 2003
Number of shared co-authors 2
Wellcome Sanger Institute
Career Start Year 2002
Number of shared co-authors 5
Broad Institute of MIT and Harvard
Career Start Year 2002
Number of shared co-authors 0
Broad Institute of MIT and Harvard
Career Start Year 2001
Number of shared co-authors 21
National Human Genome Research Institute, National Institutes of Health
Career Start Year 2000
Number of shared co-authors 8
St. Jude Children's Research Hospital
Career Start Year 1999
Number of shared co-authors 8
Invitae Corporation
Career Start Year 1998
Number of shared co-authors 4
University of Oxford
Career Start Year 1996
Number of shared co-authors 5
QIMR Berghofer Medical Research Institute
Career Start Year 1996
Number of shared co-authors 5
Changhai Hospital, Second Military Medical University
Career Start Year 1992
Number of shared co-authors 24
Institute of Cancer Research
Career Start Year 1991
Number of shared co-authors 14
Baylor College of Medicine
Career Start Year 1982
Number of shared co-authors 17

Collaborators

Clinical Genetics Branch, National Cancer Institute
Co-authored papers 26
Frederick National Laboratory for Cancer Research
Co-authored papers 8
National Cancer Institute, National Institutes of Health
Co-authored papers 7
Clinical Genetics Branch, National Cancer Institute (NCI)
Co-authored papers 7
National Cancer Institute
Co-authored papers 5
National Cancer Institute
Co-authored papers 5
Children's Hospital of Philadelphia
Co-authored papers 5
National Cancer Institute
Co-authored papers 5
Children's Hospital of Philadelphia
Co-authored papers 5
National Cancer Institute
Co-authored papers 4
Co-authored papers 4
Perelman School of Medicine, University of Pennsylvania
Co-authored papers 4
National Cancer Institute
Co-authored papers 4
Geisinger Medical Center
Co-authored papers 4
Co-authored papers 4
Center for Data-Driven Discovery in Biomedicine, Children's Hospital of Philadelphia
Co-authored papers 3
The Center for Applied Genomics, Children's Hospital of Philadelphia
Co-authored papers 3
Children's Hospital of Philadelphia
Co-authored papers 3
Frederick National Laboratory for Cancer Research
Co-authored papers 3
National Cancer Institute
Co-authored papers 3
National Cancer Institute, National Institutes of Health
Co-authored papers 3
National Cancer Institute, 9609 Medical Center Drive
Co-authored papers 3
Children's Hospital of Philadelphia
Co-authored papers 2
Co-authored papers 2
Co-authored papers 2
National Cancer Institute, National Institutes of Health
Co-authored papers 2
Co-authored papers 2
Perelman School of Medicine, University of Pennsylvania, USA Abramson Cancer Center
Co-authored papers 2
Perelman School of Medicine, University of Pennsylvania
Co-authored papers 2
Oregon Research Institute
Co-authored papers 2